Keywords: astrazenca, ends, its, deal, artherogenics, anglo-swedish, drug

AstraZenca ends its deal with ArtheroGenics

Article | 30 April 2007

Print This

Anglo-Swedish drug major AstraZeneca says that it has terminated its collaboration with US drugmaker AtheroGenics after the drug they were ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in